发明授权
- 专利标题： Heteroaryl compounds as 5-HT4 receptor ligands
- 专利标题（中）： 杂芳基化合物作为5-HT4受体配体
-
申请号： US13982486申请日： 2012-01-05
-
公开(公告)号： US09079894B2公开(公告)日： 2015-07-14
- 发明人: Ramakrishna Nirogi , Abdul Rasheed Mohammed , Suresh Yarlagadda , Srinivasa Rao Ravella , Anil Karbhari Shinde , Ramasastri Kambhampati , Praveen Kumar Roayapalley , Pradeep Jayarajan , Gopinadh Bhyrapuneni , Sriramachandra Murthy Patnala , Jyothsna Ravula , Venkateswarlu Jasti
- 申请人： Ramakrishna Nirogi , Abdul Rasheed Mohammed , Suresh Yarlagadda , Srinivasa Rao Ravella , Anil Karbhari Shinde , Ramasastri Kambhampati , Praveen Kumar Roayapalley , Pradeep Jayarajan , Gopinadh Bhyrapuneni , Sriramachandra Murthy Patnala , Jyothsna Ravula , Venkateswarlu Jasti
- 申请人地址： IN Hyderabad
- 专利权人： SUVEN LIFE SCIENCES LTD
- 当前专利权人： SUVEN LIFE SCIENCES LTD
- 当前专利权人地址： IN Hyderabad
- 代理机构： Iphorgan Ltd.
- 优先权： IN3203/CHE/2011 20110919
- 国际申请： PCT/IN2012/000011 WO 20120105
- 国际公布： WO2013/042135 WO 20130328
- 主分类号： A61K31/445
- IPC分类号： A61K31/445 ; C07D401/00 ; C07D405/00 ; C07D409/00 ; C07D411/00 ; C07D413/00 ; C07D417/00 ; C07D419/00 ; C07D421/00 ; C07D211/22 ; C07D211/32 ; C07D413/14 ; C07D413/06
摘要：
The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptors.
公开/授权文献
- US20140187581A1 HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS 公开/授权日：2014-07-03
信息查询
IPC分类:
